Table 4 The baseline characteristics of patients of previous studies
Location of Study | Usage | DVT | PE | Other adverse events | Statistical differences |
|---|---|---|---|---|---|
UAE (2011) | IV | Not mentioned | 1/20 | Not mentioned | NS |
U.S. (2013) | IV | 0 | 0 | 0 | NS |
Turkey (2014) | IV and Topical | 1/41 | 0 | 0 | NS |
U.S. (2015) | IV | 2/46 | 0 | 9/46 | NS |
China (2016) | IV | 0 | 0 | 0 | NS |
South Korea (2017) | Topical | Not mentioned | Not mentioned | Not mentioned | NS |
U.S. (2017) | IV | 0 | 0 | 0 | NS |
China (2019) | IV and topical | 1/192 and 1/135 | 0 | 2/192 and 0/135 | NS |